TY - JOUR
T1 - Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study
AU - te Kampe, R.
AU - Janssen, M.
AU - van Durme, C.
AU - Jansen, T.L.
AU - Boonen, A.
N1 - Funding Information:
This work was supported by the Maastricht University Medical Centre+/ VieCuri Science Funds. 1R. te Kampe, MSc, Department of Internal Medicine, Maastricht University Medical Center, Care and Public Health Research Institute (CAPHRI), Maastricht University, Department of Rheumatology, VieCuri Medical Center; 2M. Janssen, MD, PhD, T.L. Jansen, MD, PhD, Department of Rheumatology, VieCuri Medical Center; 3C. van Durme, MD, Department of Internal Medicine, Maastricht University Medical Center, the Netherlands, Centre Hospitalier Chrétien, Liège, Belgium; 4A. Boonen, Prof, MD, PhD, Department of Internal Medicine, Maastricht University Medical Center, Care and Public Health Research Institute (CAPHRI), Maastricht University, the Netherlands. The authors report no conflicts of interest. Address correspondence to R. te Kampe, Department of Rheumatology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands. Email: [email protected]. Accepted for publication June 12, 2020.
Publisher Copyright:
Copyright © 2021. All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Objective. Research findings in gout result predominantly from studies about men and might not be generalizable to women. To improve insight into sex differences in gout, our study compared clinical characteristics and comorbidities of female and male patients with gout, and explored the influence of menopause on these differences.Methods. Data from patients referred to 2 rheumatology clinics and diagnosed with gout were used. Clinical characteristics and comorbidities of each sex were compared univariately. Sex difference in comorbidities were further explored in multivariate logistic regression analyses adjusting for age, BMI, smoking, and alcohol consumption in both the total group and in those with gout onset >= 55 years (as a surrogate for menopausal state).Results. There were 954 patients, including 793 (83%) men, included. Women were on average older (65 vs 62 yrs), were more often obese (54% vs 36%), had a higher serum uric acid (sUA) level (0.53 vs 0.49 mmol/L), used diuretics more often (60% vs 30%), and consumed alcohol less frequently (47% vs 72%). Additionally, women more frequently had reduced renal function (64% vs 31%), hypertension (78% vs 56%), heart failure (23% vs 12%), and type 2 diabetes (39% vs 17%; all P < 0.05). In those with gout onset >= 55 years, differences in comorbidities were less pronounced and disappeared after adjusting for lifestyle.Conclusion. Our study confirmed sex differences in clinical characteristics and comorbidities among newly diagnosed patients with gout, and revealed that sex differences in cornorbidities among those with gout onset beyond the age of female menopause were strongly attenuated and fully explained by lifestyle.
AB - Objective. Research findings in gout result predominantly from studies about men and might not be generalizable to women. To improve insight into sex differences in gout, our study compared clinical characteristics and comorbidities of female and male patients with gout, and explored the influence of menopause on these differences.Methods. Data from patients referred to 2 rheumatology clinics and diagnosed with gout were used. Clinical characteristics and comorbidities of each sex were compared univariately. Sex difference in comorbidities were further explored in multivariate logistic regression analyses adjusting for age, BMI, smoking, and alcohol consumption in both the total group and in those with gout onset >= 55 years (as a surrogate for menopausal state).Results. There were 954 patients, including 793 (83%) men, included. Women were on average older (65 vs 62 yrs), were more often obese (54% vs 36%), had a higher serum uric acid (sUA) level (0.53 vs 0.49 mmol/L), used diuretics more often (60% vs 30%), and consumed alcohol less frequently (47% vs 72%). Additionally, women more frequently had reduced renal function (64% vs 31%), hypertension (78% vs 56%), heart failure (23% vs 12%), and type 2 diabetes (39% vs 17%; all P < 0.05). In those with gout onset >= 55 years, differences in comorbidities were less pronounced and disappeared after adjusting for lifestyle.Conclusion. Our study confirmed sex differences in clinical characteristics and comorbidities among newly diagnosed patients with gout, and revealed that sex differences in cornorbidities among those with gout onset beyond the age of female menopause were strongly attenuated and fully explained by lifestyle.
KW - ASSOCIATION
KW - EPIDEMIOLOGY
KW - FEMALE GOUT
KW - FOLLOW-UP
KW - HEART-FAILURE
KW - HYPERURICEMIA
KW - INDIVIDUALS
KW - RISK
KW - SERUM URIC-ACID
KW - WOMEN
KW - age of onset
KW - comorbidity
KW - gout
KW - sex
KW - uric acid
KW - MANAGEMENT
U2 - 10.3899/jrheum.200113
DO - 10.3899/jrheum.200113
M3 - Article
C2 - 32611671
SN - 0315-162X
VL - 48
SP - 286
EP - 292
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 2
ER -